Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization

doi:10.1084/jem.159.4.1105

This Article

	Full Text (PDF, 1832K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Tateno, M.
	Articles by Yoshiki, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Tateno, M.
	Articles by Yoshiki, T.


Social Bookmarking

	What's this?

ARTICLES

Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization

M Tateno, N Kondo, T Itoh, T Chubachi, T Togashi and T Yoshiki

Cocultivation of spleen cells, lymph node cells, and thymocytes of female Wistar-King-Aptekman rats with short-term cultured male adult T cell leukemia (ATL) cells in the presence of 5-bromo-2'-deoxyuridine (BrdUrd) resulted in the establishment of rat lymphoid cell lines, TARS- 1, TARL-2, and TART-1. Cytogenetic analysis of the three cell lines showed a female rat karyotype with 42 chromosomes. The surface phenotypes of TARS-1 and TART-1 were those of rat T cells. TARL-2 was only positive for rat Ia and leukocyte common antigens. The cell lines continuously produced a type C retrovirus, human T cell leukemia virus (HTLV) and expressed ATL-associated antigens. TARS-1 and TART-1, but not TARL-2 were transplantable into newborn syngeneic rats and nude mice. These results strongly indicate that HTLV not only immortalizes, but also transforms rat T cells in vitro. Adult rats immunized with either TARS-1 or TARL-2 produced antibodies specific for HTLV. The biochemical analysis of the antigens that reacted with rat sera revealed that they are the two HTLV-specific polypeptides, p24 and p28.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Takayanagi, R., Ohashi, T., Yamashita, E., Kurosaki, Y., Tanaka, K., Hakata, Y., Komoda, Y., Ikeda, S., Tsunetsugu-Yokota, Y., Tanaka, Y., Shida, H. (2007). Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner. J. Virol. 81: 5908-5918 [Abstract] [Full Text]
Mosley, A. J., Meekings, K. N., McCarthy, C., Shepherd, D., Cerundolo, V., Mazitschek, R., Tanaka, Y., Taylor, G. P., Bangham, C. R. (2006). Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. Blood 108: 3801-3807 [Abstract] [Full Text]
Miyazato, P., Yasunaga, J.-i., Taniguchi, Y., Koyanagi, Y., Mitsuya, H., Matsuoka, M. (2006). De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice. J. Virol. 80: 10683-10691 [Abstract] [Full Text]
Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M. (2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol. 76: 7010-7019 [Abstract] [Full Text]
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., Kannagi, M. (2001). Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity. JNCI J Natl Cancer Inst 93: 1775-1783 [Abstract] [Full Text]
Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M. (2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol. 74: 9610-9616 [Abstract] [Full Text]
Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Takemura, F., Hirokawa, K., Yoshiki, T., Yagita, H., Okumura, K., Kannagi, M. (2000). Development of Human T-Cell Leukemia Virus Type 1-Transformed Tumors in Rats following Suppression of T-Cell Immunity by CD80 and CD86 Blockade. J. Virol. 74: 428-435 [Abstract] [Full Text]
Koya, Y., Ohashi, T., Kato, H., Hanabuchi, S., Tsukahara, T., Takemura, F., Etoh, K.-i., Matsuoka, M., Fujii, M., Kannagi, M. (1999). Establishment of a Seronegative Human T-Cell Leukemia Virus Type 1 (HTLV-1) Carrier State in Rats Inoculated with a Syngeneic HTLV-1-Immortalized T-Cell Line Preferentially Expressing Tax. J. Virol. 73: 6436-6443 [Abstract] [Full Text]
Ohashi, T., Hanabuchi, S., Kato, H., Koya, Y., Takemura, F., Hirokawa, K., Yoshiki, T., Tanaka, Y., Fujii, M., Kannagi, M. (1999). Induction of Adult T-Cell Leukemia-Like Lymphoproliferative Disease and Its Inhibition by Adoptive Immunotherapy in T-Cell-Deficient Nude Rats Inoculated with Syngeneic Human T-Cell Leukemia Virus Type 1-Immortalized Cells. J. Virol. 73: 6031-6040 [Abstract] [Full Text]
Kondo, M, Takeshita, T, Ishii, N, Nakamura, M, Watanabe, S, Arai, K, Sugamura, K (1993). Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262: 1874-1877 [Abstract]
Nakamura, T., Tsujihata, M., Shirabe, S., Matsuo, H., Ueki, Y., Nagataki, S. (1989). Characterization of HTLV-I in a T-Cell Line Established From a Patient With Myelopathy. Arch Neurol 46: 35-37 [Abstract]
Seiki, M, Hikikoshi, A, Taniguchi, T, Yoshida, M (1985). Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family. Science 228: 1532-1534 [Abstract]